We read with much interest the original investigation by Richards et al.1 They indicate that daily SSRI use in adults 50 years and older was associated with a 2-fold increased risk of clinical fragility fracture after adjustment for potential covariates. These findings are very interesting, and, as the authors state, may have important public health consequences. However, some comments on this article can be made.
Our first concern pertains to the statistical analysis. It is unclear from the article how many fractures were included in the study. Hence, we cannot judge the validity of the statistical model including numerous covariates. Also, it is not mentioned how the authors dealt with dropout and other types of fracture. Furthermore, a Cox-proportional hazards model can be used when the time to event is known, whereas patients in this study only had to notify whether they had had a fracture in the previous year. Second, the absence of a duration effect relationship is puzzling, especially in the light of an effect through bone strength. In our opinion, a major limitation of the study is the lack of precise exposure data on a daily basis for the entire follow-up period, which would have allowed proper analysis of duration effects as well as attenuation effects after discontinuation.
Thank you for submitting a comment on this article. It will be reviewed by JAMA Internal Medicine editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 5
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.